AKT3 and kidney cancer: The Glu17Lys mutation seen in the binding site of AKT3 in kidney cancer was also found in the pleckstrin homology domain of AKT1 in breast, colorectal and ovarian cancers, and results in the activation of AKT1, followed by downstream signaling and cell transformation (62).